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1. Introduction 
Five zymogens of serine amidases that require 
vitamin K for their biosynthesis have been purified 
from bovine plasma and chemically characterized. 
Prothrombin (factor II), factor VII, factor IX and 
factor X are the four traditional vitamin K-depen- 
dent clotting factors [ 11, whereas the fifth protein, 
called protein C [2] was isolated and characterized 
only recently [3-61. Evidence has been presented 
[7] indicating that protein C has a regulatory function 
in blood coagulation. Protein C can be activated to a 
serine amidase by the factor X activator from Russel’s 
viper venom or by thrombin [3]. All these proteins 
contain the vitamin K-dependent y-carboxyglutamic 
acid residues. Another protein called protein S which 
occurs in very low concentration in human plasma 
was purified (81. 
In the course of our purification of protein C from 
large volumes of bovine plasma we have found a 
previously unknown vitamin K-dependent protein, 
and devised a simple method for its purification. A 
monospecific antiserum against this protein did not 
react with any of the other vitamin K-dependent 
plasma proteins. The amino terminal sequence of this 
protein is similar to that of human protein S. Our 
antiserum against this protein also reacts with a 
vitamin K-dependent protein purified [9] and con- 
sidered to be the bovine counterpart to human 
protein S. Our procedure for the purification of 
bovine protein S and some of its properties is described 
here. 
2. Materials and methods 
The vitamin K-dependent proteins were purified 
~Ise~irrlNorth-Hollaild Biomedical Press 
from slaughterhouse blood collected as in [2]. About 
IO0 1 blood were used in a typical preparation. The 
plasma was separated from the blood cells with a 
De Lava1 blood separator. The initial steps in the 
purification of protein S (barium citrate adsorption. 
ammonium sulphate fractionation and DEAE- 
Sephadex G-50 chromatography) were performed as 
in [2] except that the ammonium sulphate fractiona- 
tion was at 20-67s saturation instead of 40-67s. 
The pooled fractions from the DEAE-Sephadex 
chromatography (fig.1) were dialyzed against 50 mM 
Tris-HCl, 0.1 M NaCl (PI-I 7.4) and applied to a 
column (2.5 X 40 cm) of blue dextran-Sepharose in 
the same buffer. The flow rate was 24 ml/h and 8 ml 
fractions were collected. Protein S was not retained 
on the column and appeared in the first protein peak 
whereas prothrombin was eluted with I .O M NaCl. In 
some experiments traces of factor IX were removed 
by chromatography on heparin-Sepharose as in [lo]. 
The purified protein S was either stored frozen or 
dialyzed against distilled water and lyophilized. 
SDS-acrylamide disc-gel electrophoresis was as in 
[Ill. Agarose gel electrophoresis and crossed immuno- 
electrophoresis were performed using standard proce- 
dures [12,13]. Double imniuriodiffusion was as in 
[ 141. Protein S was quantitated by electroimmuno- 
assay [ 151 using a monospecific antiserum prepared 
as in [2]. The antisera against bovine factors IX, X, 
prothrombin and protein C were the same as in [2] 
whereas the antiserum against bovine factor VII was 
a gift from Dr E. Davie. 
The amino acid composition of protein S was 
determined in acid hydrolysates (24,48 and 72 h in 
6 M HCl at 110°C in vacua) with standard procedures 
[ 161 using a single column program on a Kontron 
amino acid analyser with a Durrum (DC4A) resin. 
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y-Carboxyglutamic acid was determined in base 
hydrolysates as in [ 171 with synthetic y-carboxy- 
glutamic acid as a standard. 
The amino terminal sequence of protein S was 
determined by the technique in [ 181 using a Beckman 
model 890 C sequencer. Two programs were used, a 
modification of the Beckman 1M Quadrol program 
which allows simple identification of y-carboxyglutamic 
acid (P. Fernlund, J. S., in preparation) and a standard 
program for protein sequencing [ 191. The phenyl- 
thiohydantoin residues were identified by high 
pressure liquid chromatography and thin-layer 
chromatography as in [6]. 
3. Results and discussion 
During purification of protein C a previously 
unrecognized protein, later identified as protein S, 
was found at the front of the prothrombin peak 
during DEAE-Sephadex chromatography (fig.1). 
Prothrombin was removed by blue dextran-Sepharose 
chromatography. Some preparations were contami- 
nated with factor IX which was removed by heparin- 
agarose chromatography [lo]. 
A typical preparation from 100 1 bovine blood 
gave 140 mg of protein S. A monospecific antiserum 
against protein S was used for quantitation of the 
Prothrombin 
2000 3000 LOO0 
Effluent volume (ml) 
Fig.1. Chromatography of ammonium sulphate-fractionated material on a column of DEAL-Sephadex A 50 (5 X 52 cm) in 
0.1 M phosphate buffer 1 mM benzamidine-HCl (pH 6.0). Elution was accomplished with a linear gradient of NaCl (0.15-0.55 M) 
2000 ml in each chamber. The column was eluted at 90 ml/h and 10 fractions were collected per hour. The column effluent was 
monitored immunochemically with antisera against protein S, prothrombin and factor IX. The positions of the peaks containing 
protein C and factors X, ahd X, (shaded) were known from previous experiments. 
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protein by electroimmunoassay. The method did not 
allow precise measurements of protein S in plasma 
due to the low concentration of the protein. Barium 
citrate adsorption of the plasma however appeared to 
remove the protein quantitatively. The recovery of 
protein S measured from the barium citrate eluate 
was 35%. 
On SDS-polyacrylamide gel electrophoresis puri- 
fied protein S, both reduced and unreduced, appeared 
as a doublet (fig.2). This was not due to contamina- 
tion with any of the previously characterized K-depen- 
dent plasma proteins since purified protein S did not 
react with antisera against any of these (fig.3). Protein S 
binds Ca” and its anodal electrophoretic mobility in 
agarose gel was lower in barbital buffer containing 
Ca” than in the same buffer containing EDTA instead 
of Ca’+ (fig.4). A single band was seen in both buffers. 
i 
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Pig.2. SDS-polyacrylamide gel electrophoresis of purified 
bovine protein S. Unreduced sample to the left and reduced 
to the right. About 7 ~g protein was loaded on the gels. 
S X 
IX 
VII 
C 
Fig.3. Double immunodiffusion of purified bovine protein S 
(center well) against antisera prepared against bovine factor VII, 
factor IX, factor X, prothrombin (factor II), protein C and 
protein S. 
There was no heterogeneity in the amino terminal 
part of the molecule since sequenator degradation 
gave a unique amino terminal sequence and indicated 
that the protein was > 90% pure. The reason for the 
heterogeneous appearance of the purified protein on 
SDS-acrylamide gels is not known. 
SDS-acrylamide gel electrophoresis revealed that 
protein S consisted of a single polypeptide chain with 
an app. mol. wt 65 000 for the reduced protein based 
on the major protein band in the doublet. The amino 
acid composition of bovine protein S is shown in 
table 1. It was arbitrarily calculated relative to 30 
residues of alanine which gives the apoprotein mol. wt 
+ - 
CZI 
2+ 
EDTA 
l:ip.4. Agarose gel electrophoresis of purified bovine protein S 
in 0.075 M barbital buffer (pH 8.6) with 2 mM Ca’+ or 
2 mM LDTA. The electrophorctic pattern of bovine plasma 
is shown as a reference. 
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Table 1 
Amino acid composition of acid hydrolysatc of 
bovine protein S” 
- 
Amino acid Residues/molecule 
_____- 
Lysine 35.0 
Histidine 7.2 
Arginine 17.2 
Half-cystine 26.0 
Aspartic acid 58.1 
Thrconincb 27.5 
Serineb 41.7 
Glutamic acid 64.0 
Proline 24.9 
Giycinc 37.9 
Alaninc 30 
ValineC 39.0 
Methionine 9.4 
IsoleucimF 25.9 
Leucinc 41.7 
Tyrosine 15.8 
Phenylalanine 20.6 
Tryptophand 5.3 
Total 527.2 
_~____ 
a Calculated relative to thirty residues of alanine which gives 
a mol. wt 57 100 for the apoprotcin 
b Extrapolated to zero time hydrolysis 
’ 72 h hydrolysis value 
d Determined spectrophotometrically [ 201 
57 100. Protein S contains hexose amine but it was 
not quantitated. The amino acid composition is in 
good agreement with that obtained [9]. The y-car- 
boxyglutamic acid content of protein S was 9.3 
residues/mol protein when calculated relative to 
aspartic acid in the base hydrolysate. This can be 
compared with the y-carbouyglutamic acid content of 
10 residues/mol in prothrombin [ 17,211 and the 12 
residues in factor X [22]. 
The amino-terminal sequence of bovine protein S 
was: 
Ala-Asn-Thr-Leu-Leu-Gla-Gla-Th-Lys-Lys- 
Gly-Asn-Leu 
where Gla stands for y-carboxyglutamic acid. Only 
13 residues could be identified using either the modi- 
fied program (P. Fernlund, J. S., in preparation) which 
allowed unambigous identification of y-carboxy- 
glutamic acid in positions 6 and 7 or a standard 
program for sequenator degradation of proteins. The 
sequence of bovine protein S shows a striking homology 
to the sequences of the other vitamin K-dependent 
plasma proteins as shown in fig.5. 
The results presented here agree well with those in 
[9]. Our purification procedure is however shorter 
and does not expose the protein to denaturing condi- 
tions. y-Carboxyglutamic acid was also positively 
identified during sequenator degradation. The function 
Protein S Ala Asn Thr - Leu Leu 
Prothrombin Ala Asn Lys Gly Phe Leu 
Factor IX Tyr Asn Ser Gly Lys Leu 
Factor X Ala Asn Ser - Phe Leu 
Gla Gla - Thr Lys Lys Gly Asn Leu 
Glo Gla - Vol Arg Lys Gly Asn Leu 
Gla Gla Phe Vol Arg - Gly Asn Leu 
Gla Gla - Vol Lys Gln Gl Y Asn Leu 
Protein C Ala Asn Ser - Phe Leu Gla Gla - Leu Arg Pro Gly Asn Vat 
Factor VII Ala Asn - Gly Phe Leu Gla Gla - Leu Leu Pro Gly Ser Leu 
Fig.5. Comparison of the amino terminal sequences of bovine vitamin K-dependent plasma proteins. Data from [6,17,21-25). The 
presence of y-carboxyplutamic acid (Gla) in positions 6 and 7 in factor VII was inferred from the homology with the other proteins. 
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of protein S is unknown. Its similarity to the vitamin 
K-dependent clotting factors suggests that even this 
protein may be involved in blood coagulation. 
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